Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick de Zeeuw

Showing results (31-40 of 394) with videos related to

Pageof 40
Sort By:
Advances in Chronic Kidney Disease|July 26, 2011
CKD treatment: time to alter the focus to albuminuria?Dick de Zeeuw, Rulan Parekh, Sandeep Soman
Journal of the American Society of Nephrology : JASN|January 30, 2004
Clinical trial in nephrology at hard end point?Dick de Zeeuw, Pieter A de Graeff
Current Opinion in Cardiology|June 18, 2009
Albuminuria in heart failure: what do we really know?Daniela Dobre, Sandeep Nimade, Dick de Zeeuw
Nature Reviews. Endocrinology|March 27, 2013
Dual RAAS blockade has dual effects on outcomeHiddo J Lambers Heerspink, Dick de Zeeuw
Circulation|March 2, 2011
ONTARGET still OFF-TARGET?Hiddo J Lambers Heerspink, Dick de Zeeuw
The Review of Diabetic Studies : RDS|January 21, 2012
The kidney in type 2 diabetes therapyHiddo J Lambers Heerspink, Dick de Zeeuw
The Lancet. Diabetes & Endocrinology|May 11, 2016
Unmet need in diabetic nephropathy: failed drugs or trials?Dick de Zeeuw, Hiddo J L Heerspink
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2020
Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathyDick de Zeeuw, Hiddo J L Heerspink
Journal of the American Society of Nephrology : JASN|June 7, 2005
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?Liffert Vogt, Gerjan Navis, Dick de Zeeuw
Lancet (London, England)|March 16, 2005
Renoprotective therapy: is it blood pressure or albuminuria that matters?Paul E De Jong, Dick de Zeeuw
Pageof 40

Showing results (31-40 of 394) with videos related to

Sort By:
Pageof 40
Advances in Chronic Kidney Disease|July 26, 2011
CKD treatment: time to alter the focus to albuminuria?Dick de Zeeuw, Rulan Parekh, Sandeep Soman
Journal of the American Society of Nephrology : JASN|January 30, 2004
Clinical trial in nephrology at hard end point?Dick de Zeeuw, Pieter A de Graeff
Current Opinion in Cardiology|June 18, 2009
Albuminuria in heart failure: what do we really know?Daniela Dobre, Sandeep Nimade, Dick de Zeeuw
Nature Reviews. Endocrinology|March 27, 2013
Dual RAAS blockade has dual effects on outcomeHiddo J Lambers Heerspink, Dick de Zeeuw
Circulation|March 2, 2011
ONTARGET still OFF-TARGET?Hiddo J Lambers Heerspink, Dick de Zeeuw
The Review of Diabetic Studies : RDS|January 21, 2012
The kidney in type 2 diabetes therapyHiddo J Lambers Heerspink, Dick de Zeeuw
The Lancet. Diabetes & Endocrinology|May 11, 2016
Unmet need in diabetic nephropathy: failed drugs or trials?Dick de Zeeuw, Hiddo J L Heerspink
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2020
Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathyDick de Zeeuw, Hiddo J L Heerspink
Journal of the American Society of Nephrology : JASN|June 7, 2005
Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?Liffert Vogt, Gerjan Navis, Dick de Zeeuw
Lancet (London, England)|March 16, 2005
Renoprotective therapy: is it blood pressure or albuminuria that matters?Paul E De Jong, Dick de Zeeuw
Pageof 40